Heparin-induced thrombocytopenia

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 10, Issue 4, 1996, Pages 521-530

  Shorten, G D ^a   Comunale, M E ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

cardiopulmonary bypass; heparin; thrombocytopenia; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; ANCROD; ARGATROBAN; DANAPAROID; DESULFATOHIRUDIN; DEXTRAN; DIPYRIDAMOLE; HEPARIN; ILOPROST; IMMUNOGLOBULIN G; LEPIRUDIN; STREPTOKINASE; TEDELPARIN; UROKINASE; WARFARIN;

ANTIBODY COMBINING SITE; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; DRUG PROTEIN BINDING; FIBRINOLYTIC THERAPY; HEART CATHETERIZATION; HEPARINIZATION; HUMAN; LUNG EMBOLISM; PATHOPHYSIOLOGY; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE AGGREGATION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOEMBOLISM; TREATMENT PLANNING;

EID: 0029924760     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(05)80018-7     Document Type: Review

References (167)

1. Copley AL Robb TP The effect of heparin on the platelet count in dogs and mice Am J Physiol 133 1941 248
2. Fidlar E Jaques LB The effect of commercial heparin on the platelet count J Lab Clin Med 33 1948 1410 1423
3. Weismann RE Tobin RW Arterial embolism occurring during systemic heparin therapy Arch Surg 76 1958 219 227
4. Green D Harris K Reynolds N Heparin immune thrombocytopenia: Evidence for a heparin-platelet complex as the antigenic determinant J Lab Clin Med 91 1978 167 175
5. Chong BH Pitney WR Castaldi PA Heparin-induced thrombocytopenia: Association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation Lancet 12 1982 1246 1249
6. Sandler RM Seifer DB Morgan K Heparin-induced thrombocytopenia and thrombosis: Detection and specificity of a platelet-aggregating IgG Am J Clin Pathol 83 1985 760 764
7. Kelton JG Sheridan D Brian H Clinical usefulness of testing for a heparin-dependent platelet aggregating factor in patients with suspected heparin-associated thrombocytopenia J Lab Clin Med 103 1984 606 612
8. Sheridan D Carter C Kelton JG A diagnostic test for heparin-induced thrombocytopenia Blood 67 1986 27 30
9. Bell WR Tomasulo PA Alving BM Thrombocytopenia occurring during the administration of heparin. A prospective study in 52 patients Ann Intern Med 85 1976 155 160
10. King DJ Kelton JG Heparin-associated thrombocytopenia Ann Intern Med 100 1984 535 540
11. Powers PJ Kelton JG Carter CJ Studies on the frequency of heparin-associated thrombocytopenia Thromb Res 33 1984 439 443
12. Cines DB Kaywin P Bina M Heparin-associated thrombocytopenia N Engl J Med 303 1980 788 795
13. Ansell J Slepchuk N Kumar R Heparin induced thrombocytopenia: A prospective study Thromb Haemost 43 1980 61 65
14. Stevenson M Thrombocytopenia during heparin therapy N Engl J Med 295 1976 1200 1201
15. Gallus AS Goodall KT Heparin-associated thrombocytopenia: A prospective study XVII Congress of the International Society of Haematology 1978 961
16. Cimo PL Moake JL Weinger RS Heparin induced thrombocytopenia: Association with a platelet aggregating factor and arterial thromboses Am J Hamatol 6 1979 125 133
17. Laake Collect K Eika C Hamborg T Heparin-induced thrombocytopenia—An investigation in Norwegian patients Tidsskr Nor Laegeforen 98 1978 641
18. Eika C Godal HC Laake K Low incidence of thrombocytopenia during treatment with hog mucosa heparin XVII Congress of the International Society of Haematology 961 1978
19. Powers PJ Cuthbert D Hirsch J Thrombocytopenia found uncommonly during heparin therapy JAMA 241 1979 2396 2397
20. Ansell JE Price JM Shah S Heparin-induced thrombocytopenia: What is its real frequency? Chest 88 1985 878 882
21. Holm HA Eika C Laake K Thrombocytes and treatment with heparin from porcine mucosa Scand J Haematol 25 1980 81 84
22. Eika C Godal HC Laake K Low incidence of thrombocytopenia during treatment with hog mucosa and beef lung heparin Scand J Haematol 25 1980 19 24
23. Gallus AS Goodall KT Beswick W Heparinassociated thrombocytopenia: Case report and prospective study Aust NZ J Med 10 1980 25 31
24. Olin J Graor R Heparin-associated thrombocytopenia N Engl J Med 304 1981 609
25. Romeril KR Anzimlt CMH Hamer JW Heparin-induced thrombocytopenia: Case reports and a prospective study NZ Med J 95 1982 267 269
26. Cipolle RJ Rodvold KA Seifert R Heparin-associated thrombocytopenia: A prospective evaluation of 211 patients Ther Drug Monit 5 1983 205 211
27. Graves EJ 1989 Summary, National Hospital Discharge Survey Advance Data From Vital and Health Statistics (No. 199) 1991 National Center For Health Statistics Hyattsville, MD 4 8
28. Demasi R Bode AP Knupp C Heparin-induced thrombocytopenia Am Surg 60 1994 26 29
29. Howe SE Lynch DM An enzyme-linked immunosorbent assay for the evaluation of thrombocytopenia induced by heparin J Lab Clin Med 105 1985 554 559
30. Fratantoni JC Pollet R Gralnick HR Heparin-induced thrombocytopenia: Confirmation of diagnosis with in vitro methods Blood 45 1975 395 401
31. Chong BH Grace CS Rozenberg MC Heparin-induced thrombocytopenia: Effect of heparin platelet antibody on platelets Br J Haematol 49 1981 531 540
32. Babcock RB Dumper CW Scharfman WB Heparin-induced immune thrombocytopenia N Engl J Med 295 1976 237 241
33. Rhodes GR Dixon RH Silver D Heparin induced thrombocytopenia: Eight cases with throbotic-hemorrhagic complications Ann Surg 186 1977 752 758
34. Kosfeld RE Lansing AM Masri Z Heparin-induced thrombocytopenia and recurrent thromboembolism in siblings Am J Hematol 18 1985 421 423
35. Warkentin TE Hayward CP Boshkov LK Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: an explanation for the thrombotic complications of heparin-induced thrombocytopenia Blood 84 1994 3691 3699
36. (letter) Wolf H Wick G Antibodies interacting with, and corresponding binding site for, heparin on human thrombocytes Lancet 2 1986 222 223
37. Szatkowski NS Kunicki TJ Aster RH Identification of glycoprotein Ib as a target for autoantibody in idiopathic (autoimmune) thrombocytopenic purpura Blood 67 1986 310 315
38. Stricker RB Reyes PT Corash L Evidence that a 210,000-molecular weight glycoprotein (GP 210) serves as a plate-let Fc receptor J Clin Invest 79 1987 1589
39. Moore A Ross GD Nachman RL Interaction of platelet membrane receptors with von Willebrand factor, ristocetin, and the Fc region of immunoglobulin G J Clin Invest 62 1978 1053
40. Adelman B Sobel M Fujimura Y Heparin-associated thrombocytopenia: Observations on the mechanism of platelet aggregation J Lab Clin Med 113 1989 204 210
41. Kelton JG Smith JW Warkentin TE Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4 Blood 83 1994 3232 3239
42. Amiral J Bridey F Dreyfus M Platelet factor 4 complexes to heparin is the target for antibodies generated in heparin-induced thrombocytopenia Thromb Haemost 68 1992 95 102
43. Gollub S Ulin AW Heparin-induced thrombocytopenia in man J Lab Clin Med 59 1962 430 435
44. Natelson EA Lynch EC Alfrey CP Heparin-induced thrombocytopenia. An unexpected response to treatment of consumption coagulopathy Ann Intern Med 71 1969 1121 1125
45. Kelton JG Heparin-induced thrombocytopenia Hemostasis 16 1986 173 186
46. Nelson JD Lerner RG Goldstein R Heparin induced thrombocytopenia Arch Intern Med 138 1978 548 552
47. Kappa JR Fisher CA Berkowitz HD Heparin-induced platelet activation in sixteen surgical patients: Diagnosis and Management J Vasc Surg 5 1987 101 109
48. Roberts B Rosato FE Rosato EF Heparin-A cause of arterial emboli? Surgery 55 1964 803 808
49. Barker CF Rosato FE Roberts B Peripheral arterial embolism Surg Gynecol Obstet 123 1966 22 26
50. Kaupp HA Roberts B Arterial embolization during subcutaneous heparin therapy Case report. J Cardiovasc Surg 13 1972 210 212
51. White PW Sadd JR Nensel RE Thrombotic complications of heparin therapy. Including six cases of heparin-induced skin necrosis Ann Surg 190 1979 595 608
52. Levine LE Bernstein JE Soltani K Heparin-induced cutaneous necrosis to injection sites. A sign of potentially lethal complications Arch Dermatol 119 1983 400 403
53. Platell CFE Tan EGC Hypersensitivity reactions to heparin: Delayed onset thrombocytopenia and necrotizing skin lesions Aust NZ J Surg 56 1986 621 623
54. Doty JR Alving BM McDonnell DE Heparin-associated thrombocytopenia in the neurosurgical patient Neurosurgery 19 1986 69 72
55. (letter) Heeger PS Backstom JT Heparin flushes and thrombocytopenia Ann Intern Med 105 1986 143
56. Cines DB Tomaski A Tannenbaum S Immune endothelial cell injury in heparin-associated thrombocytopenia N Engl J Med 316 1987 581 589
57. Horellou MH Conrad J Lecrubier C Persistent heparin-induced thrombocytopenia despite therapy with low molecular weight heparin Thromb Haemost 51 1984 134
58. Hrushesky WJ Subcutaneous heparin-induced thrombocytopenia Arch Intern Med 138 1978 1489
59. Kapsch DN Adelstein EH Rhodes GR Heparin-induced thrombocytopenia thrombosis, and hemorrhage Surgery 86 1979 148
60. Bailey RT Jr Ursick JA Heim KL Heparin-associated thrombocytopenia: A prospective comparison of bovine lung heparin, manufactured by a new process, and porcine intestinal heparin Drug Intell Clin Pharm 20 1986 374
61. Bell WR Royall RM Heparin-associated thrombocytopenia: A comparison of three heparin preparations N Engl J Med 303 1980 902 907
62. Green D Martin GJ Shoichet SH Thrombocytopenia in a prospective, randomized, double-blind trial of bovine and porcine heparin Am J Med Sci 288 1984 60
63. McDuffie NM Dietrich CP Nader HB Electrofocusing of heparin: Fractionation of heparin into 21 components distinguishable from other acidic mucopolysaccharides Biopolymers 14 1975 1473 1486
64. McKay DG Disseminated Intravascular Coagulation—An Intermediary Mechanism 1965 P.B. Hoeber New York 1
65. Thunberg L Lindahl U Tengblad A On the molecular-weight-dependence of the anticoagulant activity of heparin Biochem J 181 1979 241 243
66. Eika C Anticoagulant and platelet aggregating activities of heparin Thromb Res 2 1973 349 360
67. Salzman EW Rosenberg RD Smith MH Effect of heparin and heparin fractions on platelet aggregation J Clin Invest 65 1980 64 73
68. Bell WR Anderson ND Anderson AO Heparin-induced coagulopathy J Lab Clin Med 89 1977 741 750
69. (letter) Hammerschmidt DE Thrombocytopenia during heparin therapy N Engl J Med 295 1976 1200
70. Makhoul RG Greenberg CS McCann RL Heparin-associated thrombocytopenia and thrombosis: A serious clinical problem and potential solution J Vasc Surg 4 1986 522 528
71. Rhodes GR Dixon RH Silver D Heparin induced thrombocytopenia with thrombotic and hemorrhagic manifestations Surg Gynecol Obstet 136 1973 409 416
72. Kakkasseril JS Cranley JJ Panke T Heparin-induced thrombocytopenia: Aprostpective study of 142 patients J Vasc Surg 2 1985 382 384
73. Kapsch D Silver D Heparin-induced thrombocytopenia with thrombosis and hemorrhage Arch Surg 116 1981 1423 1427
74. Klein HG Bell WR Disseminated intravascular coagulation during heparin therapy Ann Intern Med 80 1974 237 481
75. Silver D Kapsch DN Tsoi EKM Heparin-induced thrombocytopenia, thrombosis and hemorrhage Ann Surg 198 1983 301 306
76. Hawkins KA Schwartz MJ Heparin-related thrombosis after myocardial infarction Am Heart J 108 1984 1543 1544
77. Olinger GN Hussey CV Olive JA Cardiopulmonary bypass for patients with previously documented heparin-induced platelet aggregation J Thorac Cardiovasc Surg 87 1984 673 677
78. Battey PM Salam AA Venous gangrene associated with heparin-induced thrombocytopenia Surgery 97 1985 618 620
79. Smith JP Walls JT Muscato MS Extracorporeal circulation in a patient with heparin-induced thrombocytopenia Anesthesiology 62 1985 363 365
80. Meytes D Ayalon H Virag I Heparin-induced thrombocytopenia and recurrent thrombosis in pregnancy A case report. J Repord Med 31 1986 993 996
81. Platell CFE Tan EGC Hypersensitivity reactions to heparin. Delayed onset thrombocytopenia and necrotizing lesions Aust NZ J Surg 56 1986 621
82. Levine LE Bernstein JE Soltani K Heparin-induced cutaneous necrosis unrelated to injection sites. A sign of potentially lethal complications Ann Dermatol 119 1983 400
83. White PW Sadd JR Nensel RE Thrombotic complications of heparin therapy including six cases of heparin-induced skin necrosis Ann Surg 190 1979 595 608
84. Baird RA Convery FR Arterial thromboembolism in patients receiving systemic heparin therapy. A complication associated with heparin-induced thrombocytopenia J Bone Joint Surg (Am) 59 1977 1061
85. Leroy J Leclere MH Delahousse B Treatment of heparin-associated thrombocytopenia and thrombosis with low molecular weight heparin (CY 216) Semin Thromb Hemost 11 1985 326
86. (letter) Krueger SK Andres E Weinand E Thrombolysis in heparin-induced thrombocytopenia with thrombosis Ann Intern Med 103 1985 159
87. Atkinson JLD Sundt TM Jr Kazmier FJ Heparin-induced thrombocytopenia and thrombosis in ischemic stroke Mayo Clin Proc 63 1988 353 361
88. Dieck JA Rizo-Patron C Unisa A A new manifestation and treatment alternative for heparin-induced thrombosis Chest 98 1990 1524 1526
89. Arthur CK Grant SJB Murray WK Heparin-associated acute adrenal insufficiency Aust NZ J Med 15 1985 454
90. Findling JW Korducki JM Lahiri PK Bilateral adrenal hemorrhage associated with heparin-induced thrombocytopenia Wise Med J 86 1987 27
91. Shelley WB Sayen JJ Heparin necrosis: an anticoagulant induced cutaneous infarct J Am Acad Dermatol 7 1982 674 677
92. Stricker H Lammle B Furlan M Heparin-dependent in vitro aggregation normal platelets by plasma of a patient with heparin-induced skin necrosis. Specific diagnostic test for a rare side effect Am J Med 85 1988 721
93. Hartman AR Hood RM Anagnostopoulos CE Phenomenon of heparin-induced thrombocytopenia associated with skin necrosis J Vasc Surg 7 1988 781
94. Calhoun BC Hesser JW Heparin-associated antibody with pregnancy: Discussion of two cases Am J Obstet Gynecol 156 1987 964
95. Van Der Weyden MB Hunt H McGrath K Delayedonset heparin-induced thrombocytopenia. A potentially malignant syndrome Med J Aust 2 1983 13
96. Towne JB Bernhard VM Hussey C White clot syndrome. Peripheral vascular complications of heparin therapy Arch Surg 114 1979 372
97. Laster J Cikrit D Walker N The heparin-induced thrombocytopenia syndrome: An update Surgery 102 1987 763 770
98. (editorial) Pitney WR How safe is heparin? Med J Aust 2 1983 111 112
99. Green D Martin GJ Shoichet SH Thrombocytopenia in a prospective, randomized, double-blind trial of bovine and porcine heparin Am J Med Sci 288 1984 60 64
100. Ramirez-Lassepas M Cipolle RJ Rodvold KA Heparin-induced thrombocytopenia in patients with cerebrovascular ischemic disease Neurology 34 1984 736 740
101. Schwartz KA Royer G Kaufman DB Complications of heparin administration in normal individuals Am J Hematol 19 1985 355 363
102. Godal HC Report of the International Committee on Thrombosis and Haemostasis. Thrombocytopenia and heparin Thromb Haemost 43 1980 222 224
103. Johnson RA Lazarus KH Henry DH Heparin-induced thrombocytopenia: A prospective study Am J Hematology 17 1984 349 353
104. Kelton JG Powers PJ Carter CJ A prospective study of the usefulness of the measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura Blood 60 1982 1050
105. Pfueller SL Luscher EF The effects of aggregated immunoglobulins on human blood platelets in relation to their complement-fixing abilities. Studies of immunoglobulins of different types J Immunol 109 1972 517
106. Amiral J Bridey F Wolf M Antibodies to macromolecular platelet factor 4-heparin complexes in heparin-induced thrombocytopenia: A study of 44 cases Thromb and Haemost 73 1995 21 28
107. Laster J Silver D Heparin-coated catheters and heparin-induced thrombocytopenia J Vasc Surg 7 1988 667
108. Stewart JR Greenfield LJ Transvenous vena caval filtration and pulmonary embolectomy Surg Clin North Am 62 1982 411
109. Chong BH Castaldi PA Heparin-induced thrombocytopenia: Further studies of the effects of heparin-dependent antibodies on platelets Br J Haematol 64 1986 347
110. Kappa Jr Cottrell ED Berkowitz HD Carotid endarterectomy in patients with heparin-induced platelet activation: Comparative efficacy of aspirin and iloprost (ZK36374) J Vasc Surg 5 1987 693
111. Phelan BK Heparin-associated thrombosis without thrombocytopenia Ann Intern Med 99 1983 637
112. Sobel M Adelman B Szentpetery S Surgical management of heparin associated thrombocytopenia. Strategies in the treatment of venous and arterial thromboembolism J Vasc Surg 8 1988 395
113. Stanton PE Jr Evans JR Lefemine AA White clot syndrome South Med 81 1988 616
114. Long RW Management of patients with heparin-induced thrombocytopenia requiring cardiopulmonary bypass (letter) J Thorac Cardiovasc Surg 89 1985 950 951
115. Clifton GD Smith MD Thrombolytic therapy in heparin-associated thrombocytopenia with thrombosis Clin Pharm 5 1986 597
116. Cohen JI Cooper MR Greenberg CS Streptokinase therapy of pulmonary emboli with heparin-associated thrombocytopenia Arch Intern Med 145 1985 1725 1726
117. Cummings JM Mason TJ Chonka EV Fibrinolytic therapy of acute myocardial infarction in the heparin thrombosis syndrome Am Heart J 112 1986 407
118. Gouault-Heilmann M Huet Y Contant G Cardiopulmonary bypass with a low molecular weight heparin fraction Lancet 2 1983 1374
119. (letter) Bouvier JL Lefevre P Villain P Treatment of serious heparin-induced thrombocytopenia by plasma exchange: Report on 4 cases Thromb Res 51 1988 335
120. Nand S Robinson JA Plasmapheresis in the management of heparin-associated thrombocytopenia with thrombosis Am J Hematol 28 1988 204
121. Vender JS Matthew EB Silverman IM Heparin-associated thrombocytopenia: Alternative managements Anesth Analg 65 1986 520 522
122. Pinching AF Plasma exchange in an immunologically mediated disease Thomson RA Recent Advances in Clinical Immunology 1980 Churchill Livingstone New York 313 340
123. Smith JP Walls JT Muscato MS Extracorporeal circulation in a patient with heparin-induced thrombocytopenia and thrombosis requiring cardiac surgery Anesthesiology 62 1985 363 365
124. Makhoul RG McCann RL Austin EH Management of patients with heparin-associated thrombocytopenia and thrombosis requiring cardiac surgery Ann Thorac Surg 43 1987 617 621
125. Stocker K Fisher H Mercer J Thrombin-like snake venom proteinases Toxicon 20 1982 265 273
126. Edward MR Hatton MW Basford JM The proteolytic action of Irvine on human fibrinogen Biochem J 118 1970 603 609
127. Dormandy JA Reid HL Controlled defibrination in the treatment of peripheral vascular disease Angiology 29 1978 80 88
128. Bell WR Pitney WR Goodwin JF Therapeutic defibrination in the treatment of thrombotic disease Lancet 1 1968 490 493
129. Davis JA Sharp AA Merrick MV Controlled trial of ancrod and heparin in the treatment of deep vein thrombosis of the lower limb Lancet 1 1972 113 115
130. Demers C Ginsberg JS Brill-Edwards P Rapid anticoagulation using ancrod for heparin-induced thrombocytopenia Blood 78 1991 2194 2197
131. Bowell RE Marmion VJ McCarthy CF Treatment of central retinal vein thrombosis with ancrod Lancet 1 1970 173 174
132. Barrie WW Wood EH Crumlish P Low dosage ancrod for the prevention of thrombotic complications after surgery for fractured neck of femur Br Med J 4 1974 130 133
133. Lowe GDO Morrice JJ Fulton A Subcutaneous ancrod after operation for fractured hip. A dose ranging and feasibility study Thromb Haemost 40 1978 134 143
134. Hall RJC Young C Sutton GC Anticoagulation by ancrod for haemodialysis Br Med J 4 1970 591 593
135. Teasdale SJ Zulys VJ Mycyk T Ancrod anticoagulation for cardiopulmonary bypass in heparin-induced thrombocytopenia and thrombosis Ann Thorac Surg 48 1989 712 713
136. O-Yurvati AH Laub GW Southgate TJ Heparinless cardiopulmonary bypass with ancrod Ann Thorac Surg 57 1994 1656 1658
137. Zulys VJ Teasdale SJ Michel ER Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass Anesthesiology 71 1989 870 877
138. Spiekermann BF Lake CL Rich GF Normal activated clotting time despite adequate anticoagulation with ancrod in a patient with heparin associated thrombocytopenia and thrombosis undergoing cardiopulmonary bypass Anesthesiology 80 1994 686 688
139. Stocker KF Snake venom proteins affecting hemostasis and in fibrinolysis Stocker KF Medical Use of Snake Venom Proteins 1990 CRC Press Boston 97 160
140. Goualt-Hellman M Huet Y Contant G Cardiopulmonary bypass with a low-molecular weight heparin fraction Lancet 1983 1374
141. Altes A Martino R Gari M Heparin-induced thrombocytopenia and heart operation: Management with tedelparin Ann Thorac Surg 59 1995 508 509
142. Robitaille D Leclerc JR Laberge R Cardiopulmonary bypass with a low molecular weight heparin fraction (enoxaparin) in a patient with a history of heparin-associated thrombocytopenia J Thorac Cardiovasc Surg 103 1992 597 599
143. Massonnet-Castel S Pelissier E Bara L Partial reversal of low molecular weight heparin (PK 10169) anti-Xa activity by protamine sulfate: In vitro and in vivo study during cardiac surgery with extracorporeal circulation Haemostasis 16 1986 139 146
144. Cartier CJ Kelton JG Hirsh J The relationship between the haemorrhagic and antithrombotic properties of low molecular weight heparin in rabbit Blood 59 1982 1239 1245
145. Holmer E Soderstrom G Neutralization of unfractionated heparin and a low molecular weight (LMW) heparin fragment by protamine Thromb Haemost 50 1983 103
146. Van Dinther ThG Hol F Meuleman DG Effect of various heparinoids on heparin cofactor II mediated anti-thrombin generation in vitro Thromb Haemost 58 1987 423
147. Meuleman DG Hobbelen P Van Dedem G A novel anti-thrombotic heparinoid (Org 10172) devoid of bleeding inducing capacity Thromb Res 27 1982 353 363
148. Ireland H Lane DA Flynn A The anticoagulant effect of heparinoid Org 10172 during haemodialysis: An objective assessment Thromb Haemostas 55 1986 271 275
149. Mikhailidis DP Barradas MA Mikhailidis AM Comparison of the effects of a conventional heparin and a low molecular weight heparinoid fraction on platelet fraction Br J Clin Pharmacol 17 1984 43 48
150. Henny CHP Ten Cate H Ten Cate JW A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs J Lab Clin Med 106 1985 187 196
151. Magnani HN Heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with orgaran (Org 10172) Thromb Haemostasis 70 1993 554 561
152. Hobbelen PM Vogel GM Meuleman DG Time courses of the antithrombotic effects, bleeding enhancing effects and interactions with factors Xa and thrombin after administration of low molecular weight heparinoid Org 10172 or heparin to rats Thromb Res 48 1987 549 558
153. Ockelford PA Carter CJ Hirsch J In vivo activity of a new heparinoid Pathology 17 1985 78 81
154. Andrassv K Koderisch MK Human pharmacologic studies of a defined low-molecular-weight heparin fraction (Fragmin®): Evidence for a simultaneous inhibition of factor Xa and IIa (thrombin) Thromb Res 49 1988 601 611
155. Danhof M de Boer A Magnani HN Pharmacokinetic considerations on orgaran (Org 10172) therapy Haemostasis 22 1992 73 84
156. Doherty DC Ortel TL De Bruijn N “Heparin-free” cardiopulmonary bypass: first reported use of heparinoid (Org 10172) to provide anticoagulation for cardiopulmonary bypass Anesthesiology 73 1990 562 565
157. Schror K Dairus H Matzky R The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK36374) equipotent to PG12 in vitro Naunyn-Schmiedeberg's Arch Pharmacol 31 1981 252 258
158. Addonizio VP Fisher CA Kappa JR Prevention of heparin-induced thrombocytopenia during open heart surgery with iloprost (ZK36374) Surgery 102 1987 796 807
159. Gorman RR Blunting S Miller OV Modulation of human platelet adenylate cyclase by prostacyclin (PGX) Prostaglandins 13 1977 377 388
160. 1 and aspirin J Cardiothorac Vasc Anesth 8 1994 556 558
161. Glusa E Urban U Studies in platelet function in hirudin plasma Folia Haematol 115 1988 88 93
162. Walenga JM Pifarre R Hoppensteadt Development of r-hirudin as a therapeutic anticoagulant and antithrobotic agent Semin Thromb Haemost 15 1990 316 333
163. Walenga JM Koza MJ Park SJ Evaluation of CGP 39393 as the anticoagulant in cardiopulmonary bypass operation in a dog model Ann Thorac Surg 58 1994 1685 1689
164. Fareed D Pifarre R Walenga JM Effect of recombinant hirudin and heparin on human platelet aggregation Fed Proc 3 1989 472
165. Markwardt F Novak G Sturtzebecker J Pharmacokinetics and anticoagulant effect of hirudin in man Thromb Haemost 52 1984 160 163
166. Marki WE Wallis RB The antcoagulant and antithrombotic properties of hirudins Thromb Haemost 64 1990 344 348
167. Schwarz RP, Becker J-CP, Brooks RL, et al: The preclinical and clinical pharmacology of NOVASTAN (Argatroban): A small-molecule, direct thrombin inhibitor. J Clin Appl Thromb Haemost (in press)